CVE-2023-24892
Microsoft Edge (Chromium-based) Webview2 Spoofing Vulnerability
Microsoft Edge (Chromium-based) Webview2 Spoofing Vulnerability
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- High
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used
Microsoft Edge (Chromium-based) Webview2 Spoofing Vulnerability
Microsoft Edge (Chromium-based) Webview2 Spoofing Vulnerability
- Record
CVE-2023-24892- CVSS 3.1
- 8.2 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:L/A:N/E:U/RL:O/RC:C - Weakness
- CWE-290
- Updated
- 2026-11-02
EUVDEUVD-2023-28882
Microsoft Edge (Chromium-based) Webview2 Spoofing Vulnerability
- Record
EUVD-2023-28882- CVSS 3.1
- 8.2 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:L/A:N/E:U/RL:O/RC:C - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-wrpf-cfwg-7hxv
Microsoft Edge (Chromium-based) Webview2 Spoofing Vulnerability
Microsoft Edge (Chromium-based) Webview2 Spoofing Vulnerability
- Record
GHSA-wrpf-cfwg-7hxv- CVSS 3.1
- 7.1 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:L/A:N - Weakness
- CWE-290, CWE-601
- Updated
- 2026-11-02
NVD
Microsoft Edge (Chromium-based) Webview2 Spoofing Vulnerability
- Record
CVE-2023-24892- CVSS 3.1
- 8.2 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:L/A:N - Weakness
- CWE-601, CWE-290
- Updated
- 2026-11-02
Affected products
Public exploits
Links only. Every CVE stores no exploit code.
| Source | Link | Date |
|---|---|---|
| Exploit-DB | Microsoft Edge (Chromium-based) Webview2 1.0.1661.34 - Spoofing | 2023-04-10 |
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, Exploit-DB, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2023-24892 is a high vulnerability (CVSS 8.2) in Microsoft Edge (chromium-based), published March 14, 2023. Public exploit code exists. EPSS puts the chance of exploitation in the next 30 days at 3.52%, the 89th percentile. No source names a fixed version.